View printer-friendly version << Back

LeMaitre Vascular to Present at Upcoming November and December Investor Conferences

11/01/17

BURLINGTON, Mass., Nov. 01, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in six investor conferences in November and December.

JJ Pellegrino, Chief Financial Officer, is scheduled to present at the Canaccord Medical Technologies & Diagnostics Forum on Thursday, November 9, 2017 at the Westin Grand Central Hotel in New York City.  The Company’s presentation is scheduled to begin at 11:30 AM EST.

David Roberts, President, is scheduled to present at the Stifel 2017 Healthcare Conference on Tuesday, November 14, 2017 at the Lotte New York Palace Hotel in New York City.  The Company’s presentation is scheduled to begin at 2:45 PM EST.

Steven Chehames, Investor Relations, is scheduled to present at the Three Part Advisors Southwest IDEAS Conference on Thursday, November 16, 2017 at the Westin Dallas Hotel in Dallas.  The Company’s presentation is scheduled to begin at 8:40 AM CST.

George LeMaitre, Chairman & CEO, will participate in the Craig-Hallum Alpha Select Conference on Thursday, November 16, 2017 at the Sheraton New York Times Square Hotel in New York City.

David Roberts, President, is scheduled to present at the Piper Jaffray Healthcare Conference on Tuesday, November 28, 2017 at the Lotte New York Palace Hotel in New York City.  The Company’s presentation is scheduled to begin at 11:10 AM EST.

David Roberts, President, will participate in the Guggenheim Annual Boston Healthcare Conference on Wednesday, December 13, 2017 at the InterContinental Hotel in Boston.

About LeMaitre Vascular

LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.

Contact:  LeMaitre Vascular, Inc.
Investor Relations
Steven Chehames
+1-781-425-1659
schehames@lemaitre.com

Source: LeMaitre Vascular, Inc.